TMA friend Peter Frampton is nominated for the Rock & Roll Hall of Fame! Vote for Peter Frampton, legendary artist and myositis community advocate, every day at vote.rockhall.com. It’s easy…
Continue Reading
Tackling a good cause
TMA is grateful to Chelsi Boiardi and the New England Patriots for choosing our organization as the beneficiary of their My Cause My Cleats campaign.
Continue Reading
Vamorolone approved by FDA
Recently, the FDA announced the approval of a new drug, vamorolone, as a treatment for Duchenne muscular dystrophy (DMD), a genetic muscle disease that usually affects young boys. Understandably, this…
Continue Reading
IBM patients battle for veterans benefits
Recently, two members of TMA’s Military Veterans with Myositis Affinity Group were successful in acquiring disability benefits from the Veterans Administration. These benefits are significant. Not only are these former…
Continue Reading
Paula Eichenbrenner joins TMA
Starting November 29, 2023, TMA will have a new executive director. After a months-long national search, TMA’s Board of Directors has found the perfect candidate to serve as TMA’s executive…
Continue Reading